Co-Investigator & Presenter
Unregulated hemp THC products reaching consumers
Presented at APHA 2024
At the 2024 APHA Annual Meeting, I presented research with Chess Blacklock evaluating the marketing practices and health information provided by companies selling hemp-derived THC products. The 2018 Farm Bill legalized hemp (<0.3% THC by weight), allowing interstate sales even where cannabis is illegal, yet these products remain largely exempt from packaging and advertising restrictions that apply to state-legal cannabis.
We used Google search to identify U.S.-based companies selling hemp-derived THC products and collected data from 30 companies on product types, THC concentrations, shipping availability, legal claims, and lab testing. We applied the DISCERN tool to assess the quality of available health information on each company’s website.
Findings highlight gaps in consumer protection and health information quality in the hemp-derived THC market. This research contributes to ongoing policy discussions about regulating intoxicating cannabinoids sold outside state cannabis frameworks.